Nika Pharmaceuticals Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NIKA research report →
Price Chart
About the company
Nika Pharmaceuticals Inc. , a pharmaceutical enterprise headquartered in Henderson, Nevada, focuses on the creation of medications to address a broad spectrum of health conditions. Its research and development efforts target serious diseases including HIV/AIDS, hepatitis B and C, rheumatoid arthritis, cancer, and diabetes.
- CEO
- Dimitar Slavchev Savov
- IPO
- 2024
- HQ
- Henderson, NV, US
Get TickerSpark's AI analysis on NIKA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $429.91M
- P/E
- -5519.27
- PEG
- 55.19
- P/S
- 0.00
- P/B
- -1303.95
- EV/EBITDA
- -5502.75
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 26.05%
- ROIC
- 23.63%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-76,398
- Net Income
- $-76,398+20.2%
- EPS
- $-0.00+0.0%
- OCF Growth
- +42.7%
- FCF Growth
- +42.7%
- 52W High
- $0.97
- 52W Low
- $0.20
- 50D MA
- $0.43
- 200D MA
- $0.51
- Beta
- -2.48
- RSI (14)
- 36
- Avg Volume
- 91
No earnings-call transcripts are available for NIKA yet.
- Free Float
- 26.3%
- Shares Outstanding
- 1.05B
- Float Shares
- 275.78M
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 18, 25 | Savov Dimitar Slavchev | sell | 2,000,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our NIKA coverage
Recent articles, reports, and earnings notes.
No research on NIKA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NIKA report →Nika Pharmaceuticals, Inc. (OTCQB: NIKA) Funding Update
globenewswire.com · Aug 25
Nika Pharmaceuticals, Inc. (OTCQB: NIKA) June 2026 Update
globenewswire.com · Jun 4
Nika Pharmaceuticals, Inc. (NIKA) Signed a Consultancy Agreement with MD Global Partners LLC
globenewswire.com · Mar 6
Nika Pharmaceuticals, Inc. (NIKA) Progress Update
globenewswire.com · Dec 3
UPDATE - Nika Pharmaceuticals, Inc. to Present at the Life Sciences Virtual Investor Forum June 11th-12th
globenewswire.com · Jun 12
Nika Pharmaceuticals, Inc. to Present at the Life Sciences Virtual Investor Forum June 11th-12th
globenewswire.com · Jun 10
Nika Pharmaceuticals, Inc. (NIKA) Markets Analysis and €8.5 Billion Projected Revenue
globenewswire.com · May 19
Nika Pharmaceuticals, Inc. (NIKA) Latest Developments
globenewswire.com · Apr 11
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.